SEC Filings

424B5
KERYX BIOPHARMACEUTICALS INC filed this Form 424B5 on 07/27/2017
Entire Document
 


Table of Contents
    2,144,634 shares of our common stock reserved for future awards under our Amended and Restated 2013 Incentive Plan; and

 

    33,422,463 shares of our common stock reserved for issuance upon conversion of our Convertible Senior Notes, due 2020.

 



 

S-5